Literature DB >> 24082055

Association between circulating endostatin, hypertension duration, and hypertensive target-organ damage.

Axel C Carlsson1, Toralph Ruge, Johan Sundström, Erik Ingelsson, Anders Larsson, Lars Lind, Johan Arnlöv.   

Abstract

Our aim is to study associations between circulating endostatin, hypertension duration, and hypertensive target-organ damage. Long-term hypertension induces cardiovascular and renal remodeling. Circulating endostatin, a biologically active derivate of collagen XVIII, has been suggested to be a relevant marker for extracellular matrix turnover and remodeling in various diseases. However, the role of endostatin in hypertension and hypertensive target-organ damage is unclear. Serum endostatin was measured in 2 independent community-based cohorts: the Prospective Investigation of the Vasculature in Uppsala Seniors (PIVUS; women 51%; n = 812; mean age, 75 years) and the Uppsala Longitudinal Study of Adult Men (ULSAM; n=785; mean age, 77.6 years). Retrospective data on blood pressure measurements and antihypertensive medication (PIVUS >5 years, ULSAM >27 years), and cross-sectional data on echocardiographic left ventricular mass, endothelial function (endothelium-dependent vasodilation assessed by the invasive forearm model), and urinary albumin/creatinine ratio were available. In PIVUS, participants with ≥ 5 years of history of hypertension portrayed 0.42 SD (95% confidence interval, 0.23-0.61; P<0.001) higher serum endostatin, compared with that of normotensives. This association was replicated in ULSAM, in which participants with 27 years hypertension duration had the highest endostatin (0.57 SD higher; 95% confidence interval, 0.35-0.80; P<0.001). In addition, higher endostatin was associated with higher left ventricular mass, worsened endothelial function, and higher urinary albumin/creatinine ratio (P<0.03 for all) in participants with prevalent hypertension. Circulating endostatin is associated with the duration of hypertension, and vascular, myocardial, and renal indices of hypertensive target-organ damage. Further studies are warranted to assess the prognostic role of endostatin in individuals with hypertension.

Entities:  

Keywords:  Sweden; angiogenesis effects; antiangiogenesis effects; cohort study; endothelial cells; epidemiology; extracellular matrix; vascular stiffness

Mesh:

Substances:

Year:  2013        PMID: 24082055     DOI: 10.1161/HYPERTENSIONAHA.113.02250

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  17 in total

1.  Vastatin (the NC1 domain of human type VIII collagen a1 chain) is linked to stromal reactivity and elevated in serum from patients with colorectal cancer.

Authors:  Nicholas Willumsen; Lars Nannestad Jorgensen; Morten Asser Karsdal
Journal:  Cancer Biol Ther       Date:  2019-01-09       Impact factor: 4.742

2.  The relation of postprandial plasma glucose and serum endostatin to the urinary albumin excretion of residents with prediabetes: results from the Kyushu and Okinawa Population Study (KOPS).

Authors:  Motohiro Shimizu; Norihiro Furusyo; Yuuki Tanaka; Yoshifumi Kato; Fujiko Mitsumoto-Kaseida; Koji Takayama; Kazuya Ura; Satoshi Hiramine; Takeo Hayashi; Hiroaki Ikezaki; Takeshi Ihara; Haru Mukae; Eiichi Ogawa; Kazuhiro Toyoda; Mosaburo Kainuma; Masayuki Murata; Jun Hayashi
Journal:  Int Urol Nephrol       Date:  2016-03-16       Impact factor: 2.370

3.  Plasma Endostatin Levels at Acute Phase of Ischemic Stroke Are Associated with Post-Stroke Cognitive Impairment.

Authors:  Sifan Qian; Ruyi Li; Chenhuan Zhang; Rui Zhang; Daoxia Guo; Xiaoqing Bu; Aili Wang; Hao Peng; Jing Chen; Yonghong Zhang; Jiang He; Tan Xu; Chongke Zhong
Journal:  Neurotox Res       Date:  2020-02-08       Impact factor: 3.911

Review 4.  Endostatin in Renal and Cardiovascular Diseases.

Authors:  Mei Li; Zoran Popovic; Chang Chu; Bernhard K Krämer; Berthold Hocher
Journal:  Kidney Dis (Basel)       Date:  2021-09-09

5.  Longitudinal change in blood pressure and risk of end-stage renal disease in a community-based cohort in Okinawa.

Authors:  Tomoko Usui; Chiho Iseki; Kunitoshi Iseki; Koji Kawakami; Masaomi Nangaku
Journal:  Clin Exp Nephrol       Date:  2019-08-05       Impact factor: 2.801

6.  Basement Membrane Extracellular Matrix Proteins in Pulmonary Vascular and Right Ventricular Remodeling in Pulmonary Hypertension.

Authors:  Anjira S Ambade; Paul M Hassoun; Rachel L Damico
Journal:  Am J Respir Cell Mol Biol       Date:  2021-09       Impact factor: 6.914

7.  Serum endostatin levels are elevated in colorectal cancer and correlate with invasion and systemic inflammatory markers.

Authors:  T Kantola; J P Väyrynen; K Klintrup; J Mäkelä; S M Karppinen; T Pihlajaniemi; H Autio-Harmainen; T J Karttunen; M J Mäkinen; A Tuomisto
Journal:  Br J Cancer       Date:  2014-08-19       Impact factor: 7.640

8.  The Relation between Serum Endostatin Level and Carotid Atherosclerosis in Healthy Residents of Japan: Results from the Kyushu and Okinawa Population Study (KOPS).

Authors:  Yoshifumi Kato; Norihiro Furusyo; Yuuki Tanaka; Takatsugu Ueyama; Sho Yamasaki; Masayuki Murata; Jun Hayashi
Journal:  J Atheroscler Thromb       Date:  2017-04-20       Impact factor: 4.928

9.  Serum Biomarkers of Myocardial Remodeling and Coronary Dysfunction in Early Stages of Hypertrophic Cardiomyopathy in the Young.

Authors:  E Fernlund; T Gyllenhammar; R Jablonowski; M Carlsson; A Larsson; J Ärnlöv; P Liuba
Journal:  Pediatr Cardiol       Date:  2017-03-30       Impact factor: 1.655

10.  Association of the Serum Endostatin Level, Renal Function, and Carotid Atherosclerosis of Healthy Residents of Japan: Results from the Kyushu and Okinawa Population Study (KOPS).

Authors:  Yoshifumi Kato; Norihiro Furusyo; Yuuki Tanaka; Sho Yamasaki; Takatsugu Ueyama; Koji Takayama; Fujiko Mitsumoto-Kaseida; Masayuki Murata; Hiroaki Ikezaki; Jun Hayashi
Journal:  J Atheroscler Thromb       Date:  2018-02-02       Impact factor: 4.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.